These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 8741985)

  • 21. N3-substituted thymidine bioconjugates for cancer therapy and imaging.
    Khalil A; Ishita K; Ali T; Tjarks W
    Future Med Chem; 2013 Apr; 5(6):677-92. PubMed ID: 23617430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidermal growth factor-DNA conjugate for two-step targeting.
    Gedda L; Carlsson J
    Int J Oncol; 1997 Oct; 11(4):789-95. PubMed ID: 21528276
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Labeled Undecahydro-closo-dodecaborates Based on Azo Dyes for Boron Neutron Capture Therapy: Synthesis, Characterization, and Visualization in Cells.
    Genady AR
    Acta Chim Slov; 2012 Mar; 59(1):89-101. PubMed ID: 24061177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation of targeting proteoliposome by postinsertion of a linker molecule conjugated with recombinant human epidermal growth factor.
    Hwang SY; Cho DY; Kim HK; Cho SH; Choo J; Yoon WJ; Lee EK
    Bioconjug Chem; 2010 Feb; 21(2):345-51. PubMed ID: 20078100
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis, and evaluation of cisplatin-containing EGFR targeting bioconjugates as potential therapeutic agents for brain tumors.
    Barth RF; Wu G; Meisen WH; Nakkula RJ; Yang W; Huo T; Kellough DA; Kaumaya P; Turro C; Agius LM; Kaur B
    Onco Targets Ther; 2016; 9():2769-81. PubMed ID: 27274273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Remarkable Enhancement in Boron Uptake Within Glioblastoma Cells With Carboranyl-Indole Carboxamides.
    Narlawar R; Austin CJD; Kahlert J; Selleri S; Da Pozzo E; Martini C; Werry EL; Rendina LM; Kassiou M
    Chem Asian J; 2018 Nov; 13(21):3321-3327. PubMed ID: 30369074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis, reactivity and biological activity of N(4)-boronated derivatives of 2'-deoxycytidine.
    Nizioł J; Zieliński Z; Leś A; Dąbrowska M; Rode W; Ruman T
    Bioorg Med Chem; 2014 Aug; 22(15):3906-12. PubMed ID: 24999002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and cytotoxicity of the boron carrier pentagamaboronon-0-ol for boron neutron capture therapy against breast cancer.
    Utomo RY; Wulandari F; Novitasari D; Susidarti RA; Kirihata M; Hermawan A; Meiyanto E
    J Adv Pharm Technol Res; 2022; 13(1):70-76. PubMed ID: 35223445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Borane-conjugated poly(ester-carbonate) amphiphilic block copolymers as potential agents for boron neutron capture therapy.
    Xiong H; Qi Y; Zhang Z; Zhou D; Jing X; Huang Y
    J Control Release; 2015 Sep; 213():e39-40. PubMed ID: 27005161
    [No Abstract]   [Full Text] [Related]  

  • 30. Swollen Polyhedral Volume of the
    Londesborough MGS; Lang K; Clegg W; Waddell PG; Bould J
    Inorg Chem; 2020 Mar; 59(5):2651-2654. PubMed ID: 32045218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CHEMISTRY OF ENERGETIC ATOMS PRODUCED BY NEUTRON CAPTURE.
    Libby WF
    Science; 1941 Mar; 93(2412):283-5. PubMed ID: 17834797
    [No Abstract]   [Full Text] [Related]  

  • 32. Boron atoms as loop accelerator and surface stabilizer in platelet-type carbon nanofibers.
    Fujisawa K; Hasegawa T; Shimamoto D; Muramatsu H; Jung YC; Hayashi T; Kim YA; Endo M
    Chemphyschem; 2010 Aug; 11(11):2345-8. PubMed ID: 20544781
    [No Abstract]   [Full Text] [Related]  

  • 33. Dendritic Structures Functionalized with Boron Clusters, in Particular Carboranes, and Their Biological Properties.
    Caminade AM; Milewski M; Hey-Hawkins E
    Pharmaceutics; 2023 Aug; 15(8):. PubMed ID: 37631334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New Boron Delivery Agents.
    Beck-Sickinger AG; Becker DP; Chepurna O; Das B; Flieger S; Hey-Hawkins E; Hosmane N; Jalisatgi SS; Nakamura H; Patil R; Vicente MDGH; Viñas C
    Cancer Biother Radiopharm; 2023 Apr; 38(3):160-172. PubMed ID: 36350709
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Boron Delivery Antibody (BDA) with Boronated Specific Residues: New Perspectives in Boron Neutron Capture Therapy from an In Silico Investigation.
    Rondina A; Fossa P; Orro A; Milanesi L; De Palma A; Perico D; Mauri PL; D'Ursi P
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peptide-Drug Conjugates and Their Targets in Advanced Cancer Therapies.
    Hoppenz P; Els-Heindl S; Beck-Sickinger AG
    Front Chem; 2020; 8():571. PubMed ID: 32733853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Boron neutron capture therapy for malignant brain tumors.
    Miyatake SI; Wanibuchi M; Hu N; Ono K
    J Neurooncol; 2020 Aug; 149(1):1-11. PubMed ID: 32676954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physical, dosimetric and clinical aspects and delivery systems in neutron capture therapy.
    Farhood B; Samadian H; Ghorbani M; Zakariaee SS; Knaup C
    Rep Pract Oncol Radiother; 2018; 23(5):462-473. PubMed ID: 30263016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Boron delivery agents for neutron capture therapy of cancer.
    Barth RF; Mi P; Yang W
    Cancer Commun (Lond); 2018 Jun; 38(1):35. PubMed ID: 29914561
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.